The Role of Mechanical Circulatory Support in Patients With Severe Left Ventricular Impairment Treated With Transcatheter Aortic Valve Implantation and Percutaneous Coronary Intervention.
Aortic stenosis
Extra corporeal membrane oxygenation (ECMO)
Impella
Intravascular lithotripsy (IVL)
Left ventricular (LV) systolic dysfunction
Percutaneous coronary intervention (PCI)
Percutaneous left ventricular assist device
Transcatheter aortic valve intervention (TAVI)
Journal
Cardiovascular revascularization medicine : including molecular interventions
ISSN: 1878-0938
Titre abrégé: Cardiovasc Revasc Med
Pays: United States
ID NLM: 101238551
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
received:
09
01
2021
revised:
28
02
2021
accepted:
27
03
2021
pubmed:
21
4
2021
medline:
25
2
2023
entrez:
20
4
2021
Statut:
ppublish
Résumé
Transcatheter aortic valve implantation (TAVI) has become an established treatment for patients with severe aortic stenosis (AS) in an ever-growing patient population. It is not uncommon for patients who are undergoing TAVI to have technically difficult anatomy, simultaneous severe left ventricular (LV) impairment and/or extensive coronary artery disease. In this case series we present examples where the use of mechanical circulatory support (MCS) facilitated a safe aortic and coronary intervention in extremely complex patients who would have otherwise carried prohibitive procedural risk.
Identifiants
pubmed: 33875387
pii: S1553-8389(21)00180-9
doi: 10.1016/j.carrev.2021.03.020
pii:
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
169-175Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest VP is in receipt of honoraria and consultancy fees from Abiomed. All other authors have no conflicts of interests.